(The company’s original sales forecast is corrected in the headline and first paragraph: Stratec had previously assumed constant sales development.)
BIRKENFELD (dpa-AFX) – The diagnostics specialist Stratec (STRATEC SE) is now expecting a decline in sales for 2022 due to a surprising increase in backlogs. The drop in revenue based on constant exchange rates is likely to be five to eight percent, the company announced on Tuesday evening in Birkenfeld. Up until now, Stratec had expected sales to be at the previous year’s level. Analysts had even expected a slight increase in sales.
The company is sticking to its target of an adjusted EBIT margin (earnings before interest and taxes) of 16.5 to 18.5 percent. In the previous year, this was 18.9 percent.
In the first nine months of the current year, sales fell by 7.9 percent to EUR 207.7 million compared to the same period last year. Stratec referred to the “very tense situation within the supply chain”. Contrary to original expectations, the backlog of deliveries as a result of the difficult procurement situation for preliminary products (particularly semiconductor chips) continued to increase over the course of the third quarter.
The adjusted EBIT margin for this period is expected to be 18.3 percent. In the same period of the previous year, Stratec had achieved 21.6 percent here.
The price of the Stratec share fell by one percent on the Tradegate trading platform in an initial reaction./he/gl
Leverage must be between 2 and 20
No data